Cargando…
Systemic clearance and brain distribution of carbazole-based cyanine compounds as Alzheimer’s disease drug candidates
SLM and SLOH, two analogues of carbazole-based cyanine compounds, have been shown to inhibit β-amyloid peptide aggregation in vitro and in Alzheimer’s disease model mice, which could be potentially developed into drugs for disease treatment. To pave the way for further pharmacokinetics-pharmacodynam...
Autores principales: | Zhou, Wei, Hu, Xiaohui, Tam, Kin Yip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703966/ https://www.ncbi.nlm.nih.gov/pubmed/29180684 http://dx.doi.org/10.1038/s41598-017-16635-4 |
Ejemplares similares
-
The Use of Heptamethine Cyanine Dyes as Drug-Conjugate Systems in the Treatment of Primary and Metastatic Brain Tumors
por: Cooper, Elizabeth, et al.
Publicado: (2021) -
Cyanine conjugates in cancer theranostics
por: Li, Yang, et al.
Publicado: (2020) -
Exploration of Cyanine Compounds
as Selective Inhibitors of Protein Arginine Methyltransferases: Synthesis
and Biological Evaluation
por: Hu, Hao, et al.
Publicado: (2015) -
A Comparative Study on Cyanine Dyestuffs as Sensor Candidates for Macromolecular Crowding In Vitro and In Vivo
por: Koch, Leon, et al.
Publicado: (2023) -
Effect of morpholine and charge distribution of cyanine dyes on cell internalization and cytotoxicity
por: Wangngae, Sirilak, et al.
Publicado: (2022)